Yahya Benbouchta1,2, Imane Cherkaoui Jaouad3, Habiba Tazi4, Hamza Elorch4, Mouna Ouhenach5, Abdelali Zrhidri5, Khalid Sadki6, Abdelaziz Sefiani3,5, Jaber Lyahyai5, Amina Berraho4. 1. Department of Medical Genetics, National Institute of Health, 27, Avenue Ibn, BP 769 Agdal, 10 090, Rabat, Morocco. benbouchtayahya@yahoo.fr. 2. Laboratory of Human Pathology, Faculty of Sciences, Mohammed V University, Rabat, Morocco. benbouchtayahya@yahoo.fr. 3. Department of Medical Genetics, National Institute of Health, 27, Avenue Ibn, BP 769 Agdal, 10 090, Rabat, Morocco. 4. Ophtalmology Department, Hôpital Des Spécialités, Rabat, Morocco. 5. Research Team in Genomics and Molecular Epidemiology of Genetic Diseases, Genomic Center of Human Pathologies, Medical School and Pharmacy, University Mohammed V, Rabat, Morocco. 6. Laboratory of Human Pathology, Faculty of Sciences, Mohammed V University, Rabat, Morocco.
Abstract
BACKGROUND: Corneal dystrophies (CDs) are a heterogeneous group of bilateral, genetically determined, noninflammatory bilateral corneal diseases that are usually limited to the cornea. CD is characterized by a large variability in the age of onset, evolution and visual impact and the accumulation of insoluble deposits at different depths in the cornea. Clinical symptoms revealed bilateral multiple superficial, epithelial, and stromal anterior granular opacities in different stages of severity among three patients of this family. A total of 99 genes are involved in CDs. The aim of this study was to identify pathogenic variants causing atypical corneal dystrophy in a large Moroccan family and to describe the clinical phenotype with severely different stages of evolution. CASE PRESENTATION: In this study, we report a large Moroccan family with CD. Whole-exome sequencing (WES) was performed in the three affected members who shared a phenotype of corneal dystrophy in different stages of severity. Variant validation and familial segregation were performed by Sanger sequencing in affected sisters and mothers and in two unaffected brothers. Whole-exome sequencing showed a novel heterozygous mutation (c.1772C > A; p.Ser591Tyr) in the TGFBI gene. Clinical examinations demonstrated bilaterally multiple superficial, epithelial and stromal anterior granular opacities in different stages of severity among three patients in this family. CONCLUSIONS: This report describes a novel mutation in the TGFBI gene found in three family members affected by different phenotypic aspects. This mutation is associated with Thiel-Behnke corneal dystrophy; therefore, it could be considered a novel phenotype genotype correlation, which will help in genetic counselling for this family.
BACKGROUND: Corneal dystrophies (CDs) are a heterogeneous group of bilateral, genetically determined, noninflammatory bilateral corneal diseases that are usually limited to the cornea. CD is characterized by a large variability in the age of onset, evolution and visual impact and the accumulation of insoluble deposits at different depths in the cornea. Clinical symptoms revealed bilateral multiple superficial, epithelial, and stromal anterior granular opacities in different stages of severity among three patients of this family. A total of 99 genes are involved in CDs. The aim of this study was to identify pathogenic variants causing atypical corneal dystrophy in a large Moroccan family and to describe the clinical phenotype with severely different stages of evolution. CASE PRESENTATION: In this study, we report a large Moroccan family with CD. Whole-exome sequencing (WES) was performed in the three affected members who shared a phenotype of corneal dystrophy in different stages of severity. Variant validation and familial segregation were performed by Sanger sequencing in affected sisters and mothers and in two unaffected brothers. Whole-exome sequencing showed a novel heterozygous mutation (c.1772C > A; p.Ser591Tyr) in the TGFBI gene. Clinical examinations demonstrated bilaterally multiple superficial, epithelial and stromal anterior granular opacities in different stages of severity among three patients in this family. CONCLUSIONS: This report describes a novel mutation in the TGFBI gene found in three family members affected by different phenotypic aspects. This mutation is associated with Thiel-Behnke corneal dystrophy; therefore, it could be considered a novel phenotype genotype correlation, which will help in genetic counselling for this family.
Authors: Jayne S Weiss; Hans Ulrik Møller; Anthony J Aldave; Berthold Seitz; Cecilie Bredrup; Tero Kivelä; Francis L Munier; Christopher J Rapuano; Kanwal K Nischal; Eung Kweon Kim; John Sutphin; Massimo Busin; Antoine Labbé; Kenneth R Kenyon; Shigeru Kinoshita; Walter Lisch Journal: Cornea Date: 2015-02 Impact factor: 2.651
Authors: Björn Hammar; Neil Lagali; Stefan Ek; Stefan Seregard; Anette Dellby; Per Fagerholm Journal: Acta Ophthalmol Date: 2009-08-14 Impact factor: 3.761
Authors: Monika Ołdak; Jacek P Szaflik; Aneta Ścieżyńska; Monika Udziela; Radosław B Maksym; Beata Rymgayłło-Jankowska; Carmen Hofmann-Rummelt; Johannes Menzel-Severing; Rafał Płoski; Tomasz Żarnowski; Friedrich E Kruse; Jerzy Szaflik Journal: Cornea Date: 2014-03 Impact factor: 2.651
Authors: Cerys J Evans; Alice E Davidson; Nicole Carnt; Karla E Rojas López; Neyme Veli; Caroline M Thaung; Stephen J Tuft; Alison J Hardcastle Journal: Invest Ophthalmol Vis Sci Date: 2016-10-01 Impact factor: 4.799
Authors: Natalie A Afshari; Rosanna P Bahadur; David E Eifrig; Ida B Thogersen; Jan J Enghild; Gordon K Klintworth Journal: Mol Vis Date: 2008-03-12 Impact factor: 2.367